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Abstract 
Background: We sought to compare the incidence of incomplete revascularization (IR) and 
long-term survival (up to 20 years) after off-pump (OPCAB) versus on-pump (ONCAB) 
coronary artery bypass in a high OPCAB volume centre where OPCAB was introduced in 1996 
and has become the preferred strategy over the years.  
Methods and Results: From 1996 to 2015 a total of 7,427 OPCAB and 7128 ONCAB 
procedures were performed at Bristol Heart Institute, United Kingdom. We obtained 5423 
Propensity matched pairs for comparison. Mixed effect Cox model accounting for clustering 
due to different surgeon was used to investigate the treatment effect on mortality.  
Results: OPCAB was associated with higher rate of incomplete revascularization 13.3% versus 
6.7%; P<0.0001). Mean follow-up time was 7.8±4.6 year [max 17.3]. At 12 years OPCAB was 
associated with a marginal but significant +3% increase in overall mortality (67.4%[95%CI 
65.8-69.1] vs 64.4%[95%CI 62.7-66.2]; stratified log-rank P=0.03). When compared to 
ONCAB with complete revascularization, OPCAB with IR (HR 1.74;95%CI 1.53-1.99; 
P<0.001) and ONCAB with IR (HR 1.29; 95%CI 1.06-1.57; P=0.01) but not OPCAB with 
complete revascularization (HR 1.02;95%CI 0.94-1.11; P=0.63) were associated with 
increased risk of late mortality. 
Conclusion: Despite completeness of revascularization was achieved in the majority of 
OPCAB cases, OPCAB remained associated with a significantly higher rate of incomplete 
revascularization. This translated into a marginal but significant reduction in late survival rates 
after OPCAB when compared to ONCAB.  
Keywords: off-pump coronary artery bypass grafting; long-term survival; incomplete 
revascularization  
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Introduction 
Despite the potential advantages of avoiding cardiopulmonary bypass, there is continued 
debate as to whether off-pump coronary artery bypass grafting surgery (OPCAB) provides any 
benefit over on-pump coronary revascularization (ONCAB). In North America, OPCAB 
procedures peaked at 25% in 2004 but have declined steadily since that time [1] and currently 
this technique is used in fewer than 1 in 5 patients who undergo surgical coronary 
revascularization.  The reasons for this decline are speculative but may be partly related to both 
individual center and surgeon dissatisfaction with the procedure and the results of clinical trials 
[2-4]. In fact, the perceived benefits of OPCAB in terms of perioperative mortality and 
morbidity including stroke and renal failure were not realized in the majority of studies 
comparing the two strategy [2-4]. Furthermore the long-term effects of OPCAB on survival 
continue to be controversial [5-7]. A Cochrane Review on the subject [8] and more recent meta-
analyses concluded that all-cause mortality rates with OPCAB were higher than rates with 
ONCAB [5]. In view of these concerns, it has been recently suggested that OPCAB should be 
abandoned [9]. OPCAB is a more technically demanding procedure and result in a high rate of 
incomplete revascularization (IR) which has been advocated as a major determinant of poorer 
long term survival reported by previous study [3]. However, the magnitude of the impact of 
OPCAB on incomplete revascularization and long term survival in the real world practice 
remains unclear as well as the extent of the learning curve effect on outcomes during OPCAB. 
Current comparisons present several limitations. Randomized controlled trials available were 
limited by relatively short long term follow-up and were largely underpowered to demonstrate 
a difference in long-term survival [10-11]. Moreover, the total off-pump experience was 
relatively small in the majority of them [12].  On the other hand, in observational series, 
ONCAB has usually been the first choice strategy [6,7] thus introducing a selection bias with 
patients at higher risk undergoing OPCAB.    
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We sought to investigate the incidence of incomplete revascularization and long-term survival 
after OPCAB versus ONCAB by analysing prospectively collected data from a single 
institution where OPCAB was introduced in 1996 and has become the preferred strategy over 
the years for many surgeons. The emphasis of this study is large sample size, long term follow-
up and high OPCAB volume to shed further light as to whether these techniques offer 
comparable results. 
Methods 
The study was conducted in accordance with the principles of the Declaration of Helsinki. The 
local audit committee approved the study, and the requirement for individual patient consent 
was waived. We retrospectively analysed prospectively collected data from The National 
Institute for Cardiovascular Outcomes Research (NICOR) registry on 1 June 2015 for all 
isolated first time CABG procedures performed at the Bristol Heart Institute, Bristol United 
Kingdom from 1996 to April 2015.  Reproducible cleaning algorithms were applied to the 
database, which are regularly updated as required. Briefly, duplicate records and non-adult 
cardiac surgery entries were removed; transcriptional discrepancies harmonized; and clinical 
conflicts and extreme values corrected or removed. The data are returned regularly to the local 
units for validation.  
Further details and definition of variables are available at 
http://www.ucl.ac.uk/nicor/audits/adultcardiac/datasets. During the study period, a total of 
15,119 patients underwent first time isolated CABG; information regarding the strategy used 
(OPCAB versus ONCAB) was not available for 487 subjects and data on operating surgeon 
identification number (ID) was not available for further 80 subjects, thus leaving 14,552 for 
the final analysis. Of them 7,427 received OPCAB and 7128 ONCAB surgery (Figure 1). The 
rate of OPCAB has declined in the recent years due to changes in the staff composition with 
new attending surgeons who preferentially performed ONCAB replacing senior surgeons who 
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preferentially performed OPCAB.   Patients who were initially intended to undergo off-pump 
CABG but were converted to on-pump CABG intraoperatively (n= 32, 0.4% of off-pump 
patients) were regarded as having OPCAB. All procedures were performed by a total of 22 
surgeons (Supplementary Material). Hybrid procedures were not included in the present series. 
In case of incomplete revascularization following either OPCAB or ONCAB, subsequent 
percutaneous coronary intervention was performed only in case of recurrent symptoms.   
Surgical procedures and medication.  
The majority of patients were operated on through a median sternotomy, whereas some of the 
patients receiving single Internal thoracic arteries (ITAs) were dissected in either a pedicled or 
skeletonized fashion according to the surgeon preferences. All saphenous vein (SV) grafts were 
harvested by the open technique. The pedicled radial artery (RA) was harvested with the use 
of a harmonic scalpel or electrocautery in an open fashion. To prevent arterial graft spasm after 
harvesting, a vasodilatory cocktail was applied topically and injected intraluminally. In cases 
of on-pump strategy, intermittent, normotherimc antegrade blood cardioplegic infusion was the 
principal strategy for myocardial protection during aortic cross clamping. The left ITA was 
used to bypass the left anterior descending artery whenever possible. Choices of conduits and 
their configurations for other coronary territories were determined on the basis of conduit 
availability, number of distal targets, the target territory (right coronary vs. left circumflex 
territories), and the surgeon’s preference. Statin medications and aspirin were routinely 
prescribed to all of the patients starting from postoperative day 1 or 2 and were continued 
indefinitely, if not contraindicated, through the 6- month interval outpatient clinic visits. The 
dose of statin medication was adjusted for a target low-density lipoprotein level of <100 mg/dl. 
Study Endpoints 
All-cause mortality during follow-up was the primary endpoint. All-cause death is considered 
the most robust and unbiased index in cardiovascular research because no adjudication is 
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required, thus avoiding inaccurate or biased documentation and clinical assessments. 
Information about post-discharge mortality tracking was available for all patients (100%) and 
was obtained by linking the institutional database with the National General Register Office. 
Incomplete revascularization (IR) was defined as at least one diseased primary arterial territory. 
The rate of IR among individual surgeons and across different eras (Supplementary Material).  
Other short-term outcomes analysed were: re-exploration for bleeding, need for sternal wound 
reconstruction, postoperative cerebrovascular accident (CVA) (defined as any confirmed 
neurologic deficit of abrupt onset that did not resolve within 24 hours), postoperative dialysis, 
need for postoperative intra-aortic balloon pump (IABP) and early mortality (within 30 days).  
Pre-treatment variables 
The effect of OPCAB on outcomes of interest was adjusted for the following pre-treatment 
variables including: age, gender, body mass index (BMI); Canadian Cardiovascular Society 
(CCS) grade III or IV; New York Heart Association grade III or IV; previous myocardial 
infarction (MI) and MI within 30 days, previous percutaneous coronary intervention (PCI); 
diabetes mellitus (DM) on oral treatment or on insulin; chronic obstructive pulmonary disease 
(COPD); current smoking; serum creatinine ≥200 mmol/l, previous CVA; peripheral vascular 
disease (PVD); preoperative atrial fibrillation (AF); left main disease (LMD); number of vessel 
diseased; left ventricular ejection fraction (LVEF) between 30% and 49%; LVEF less than 
30%; non elective admission, cardiogenic shock; preoperative IABP and eras of surgery; use 
of left and right internal thoracic arteries (LITA and RITA), radial artery (RA) and saphenous 
vein graft (SVG).  
Statistical analysis 
Categorical variables are presented as frequencies and percentages and continuous variables as 
mean±standard deviation. Survival curves were constructed using Kaplan-Meier estimates and 
compared with the log-rank test. To reduce the effect of treatment selection bias and potential 
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confounding, we adjusted for differences in baseline characteristics by propensity score (PS) 
matching.  
A PS was generated for each patient from a multivariable logistic regression model based on 
pre-treatment covariates as independent variables with treatment type (OPCAB vs ONCAB) 
as a binary dependent variable [13]. The resulting propensity score represented the probability 
of a patient undergoing OPCAB (Supplementary Material). Pairs of patients undergoing 
OPCAB and OPCAB were derived using greedy 1:1 matching with a calliper of width of 0.2 
standard deviation of the logit of the PS [13] (http://www.jstatsoft.org/v42/i08/ ). The quality 
of the match was assessed by comparing selected pre-treatment variables in propensity score– 
matched patient using the standardized mean difference (SMD), by which an absolute 
standardized difference of greater than 10% is suggested to represent meaningful covariate 
imbalance. McNemar's test was used to assess the statistical significance of the risk difference 
in short term outcomes in the matched sample. The stratified log-rank test can be used to 
compare the equality of the survival curves in matched samples [14]. Finally to account for 
clustering effect due to individual surgeons, we used a mixed effect Cox model with individual 
surgeons as random effect [15] to investigate the effect of OPCAB on survival (http://CRAN.R-
project.org/package=coxme). Subgroup analysis was conducted according to the completeness 
of revascularization. The effect of IR on late mortality was tested in a fully adjusted mixed 
proportional hazard model including the original sample. All p-values <0.05 were considered 
to indicate statistical significance. All statistical analysis was performed using R Statistical 
Software (version 3.2.3; R Foundation for Statistical Computing, Vienna, Austria). 
Results 
Before matching, patients undergoing OPCAB were more likely to be older, obese while, more 
likely to have prior PCI while ONCAB patients were more likely to have 3-vessel disease. 
OPCAB patients were more likely to receive RA graft and less likely SVG and RITA grafts 
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(Table 1). PS matching selected 5423 pairs (Table 2) comparable for all variables (SMD<0.10; 
Figure 2).   
Intraoperative data and short term outcomes 
Intraoperative data and short term outcomes are summarized in Table 3. After PS matching, 
OPCAB patients received a lower number of grafts, in particular the number of patients 
receiving 4 or more grafts was higher in the ONCAB group. The circumflex artery was more 
likely to remain un-grafted during OPCAB. Overall, OPCAB was associated with a 2 fold 
increased risk of incomplete revascularization (13.6% vs 6.9%). Overall mortality was 
comparable between the two groups (1.4%). OPCAB was associated with a lower incidence of 
postoperative complications. In particular OPCAB significantly reduced the risk of 
postoperative CVA, re-exploration and need for IABP.  
Survival analysis  
Mean follow-up time was 7.8±4.6 year [max 17.3]. Survival rates are reported in Table 4. At 
12 years OPCAB was associated with a marginal but significant +3% increase in overall 
mortality (67.4%[95%CI 65.8-69.1] vs 64.4%[95%CI 62.7-66.2]; stratified log-rank P=0.03; 
Figure 3 left). When the analysis was adjusted for clustering effect due to individual surgeon 
OPCAB was confirmed to be independently associated with a 11% increased risk of late death 
(HR 1.11; 95%CI 1.05-1.20; P=0.02). Effect of individual surgeon on mortality was not 
significant (P=0.6). Subjects undergoing OPCAB with IR (51.6%[95%CI 46.8-56.3) and 
ONCAB with IR (58.2%[95%CI 51.3-65.2) showed lower 12 year survival rates when 
compared to OPCAB with complete revascularization (CR) (66.5%[95%CI 64.7-68.4]) and 
ONCAB with CR (68.1%[95%CI 66.4-69.8]) (Figure 3, right). When compared to ONCAB 
with CR, OPCAB with IR (HR 1.74;95%CI 1.53-1.99; P<0.001) and ONCAB with IR (HR 
1.29; 95%CI 1.06-1.57; P=0.01) but not OPCAB with CR (HR 1.02;95%CI 0.94-1.11; P=0.63) 
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were associated with increased risk of late mortality. To account for imbalance in risk factors 
distribution in subjects who received IR, we compared propensity matched OPCAB vs 
ONCAB according to the completeness of revascularization (Supplementary Material). 
Among, 6479 and 6625 subjects from the original sample who received CR with OPCAB and 
ONCAB respectively, we selected 4953 matched pairs. In case of complete revascularization, 
OPCAB with CR and ONCAB with CR showed comparable survival (HR 1.07;95%CI 0.98-
1.16; P=0.11). Among, 945 and 503 subjects from the original sample who received IR with 
OPCAB and ONCAB respectively we selected 4953 matched pairs (Supplementary material). 
In case of incomplete revascularization, OPCAB with IR and was associated with lower 
survival rates when compared to ONCAB with IR (HR 1.29;95%CI1.03-1.61; p=0.03).  In a 
fully adjusted including IR as covariate, IR (HR 1.25;95%CI 1.14-1.38; P<0.001) but not 
OPCAB (HR 1.06;95%CI 0.99;1.14;P=0.11) was associated with increased risk of late death 
(Table 5).    
 
Discussion 
The main finding of the present analysis was that completeness of revascularization was 
achieved in the majority of OPCAB cases but OPCAB still remained associated with a 
significantly higher rate of incomplete revascularization. IR was found to be a strong 
independent risk factor for late death and the excess of IR among OPCAB translated into a 
marginal but significant 3% increased risk of mortality at 12 years. In case of complete 
revascularization, OPCAB and ONCAB achieved comparable survival rates. However, the 
detrimental effect of incomplete revascularization on survival was more relevant in subjects 
undergoing OPCAB when compared to ONCAB. On the other hand, OPCAB was associated 
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with a trend towards less operative complications including stroke and re-exploration for 
bleeding.  
Despite the resurgence in OPCAB in the 1990s on the basis of the various purported advantages 
attributed to avoiding extracorporeal circulation, there is continued debate as to whether this 
technique provides any benefit over ONCAB. OPCAB has been consistently reported to be 
associated with higher rate of incomplete revascularization and concerns remain its potential 
detrimental effect on long-term outcomes. Kim et al. [6] recently reported on long term survival 
from high OPCAB volume Asian centre. By comparing 1070 PS matched OPCAB vs ONCAB 
pairs they found that OPCAB was associated with a 48% relative risk increase of late death 
(P<0.0001) after a median follow-up 6.4 years. In a 2014 meta-analysis, Takagi et al. [5] pooled  
randomized controlled trials and adjusted observational studies of off-pump versus on-pump 
coronary bypass surgery that had reported long-term (>5-year) all-cause mortality as an 
outcome. Pooled analysis of 5 randomized trials (1486 patients) demonstrated a statistically 
nonsignificant 14% increase in mortality with off-pump relative to on-pump (P = 0.39) and 
pooled analysis of 17 observational studies (102,820 patients) demonstrated a statistically 
significant 7% increase in mortality with off-pump relative to on-pump CABG (P=0.0004). 
Criticisms for current randomized trials comparing off-pump versus on-pump on long term 
survival include a possible bias toward including relatively low-risk patients, low off-pump 
experience of participating surgeons and relatively small sample. To address these issues, a 
large international trial that enrolled 4,752 patients, CORONARY (CABG Off or On Pump 
Revascularization Study) [2], was recently conducted. A strict criterion was applied to include 
only experienced surgeons. The 5-year results showed no significant differences between the 
2 groups with regard to death, nonfatal stroke, nonfatal myocardial infarction, or renal failure. 
However, no data are available on long term comparison.  
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The present is one of the largest series comparing OPCAB versus ONCAB with very long 
follow-up available. The patient population size was adequate to power the statistical analysis. 
We found that despite complete revascularization could be achieved in the majority of OPCAB 
cases, the rate of incomplete revascularization with OPCAB was significantly higher than 
ONCAB. This difference translated into a marginal but significant reduction of late survival 
rates with OPCAB. On the hand, OPCAB was associated with a significant reduction in the 
postoperative complications including stroke.  
It should be emphasized that the rate of incomplete revascularization in the present OPCAB 
series was particularly low (13.6%) than those reported by others and this might partially 
account for the marginal difference in late survival rates between the two strategies compared 
to other series [5,6]. In a recent report on the Veterans Affairs Continuous Improvement in 
Cardiac Surgery Program [16] involving 41,139 patients with left main and 3-vessel coronary 
artery disease, the IR rate among 6367 OPCAB cases was remarkably high (29%) compared to 
that observed in 34,772 ONCAB cases (11.0%). In accordance with previous reports [17], we 
found that incomplete revascularization was associated with poorer long term survival. In in 
the SYNTAX (Synergy Between PCI With Taxus and Cardiac Surgery) trial [18], the rates of 
IR were 43.3% for PCI and 36.8% for the surgical revascularization. IR was found to be 
associated with poorer outcomes in the PCI arm but not in the surgical revascularization arm. 
However, it should be noticed that the SYNTAC trial analysis was limited by a very short 
follow-up (3 years). We also found that survival curves between OPCAB and ONCAB are 
superimposed up to 3-4 years and then start diverging thus suggesting a delayed effect of IR 
on survival. It has been reported that patients who undergo IR are more likely to present 
multiple comorbidities and unfavourable anatomy and this could bias the data in favour of 
complete revascularization [19]. It might be possible that the high rate of IR among some of 
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the surgeons in the present series (Supplementary Material) is partially due to a selection bias 
with high risk patients operated on most senior and OPCAB experienced surgeons.  
Finally previous reports have suggested that the use of arterial grafts balance survival between 
incomplete and complete revascularization [20]. However, our analysis showed multiple 
arteries OPCAB was still associated to higher risk of IR and late mortality when compared to 
multiple arteries ONCAB.  
Limitations 
Although the data were collected prospectively, the main limitation is the retrospective 
analysis. We were unable to provide specific causes of death (cardiac vs non-cardiac) as well 
as incidence of major cardiac adverse events including myocardial infarction and repeat 
revascularization and therefore, we can only speculate that the mechanism beyond the 
differences between OPCAB and ONCAB. Another limitation of this study is that OPCAB was 
performed by experienced surgeons and the results may not be the same with surgeons in their 
learning curve period or in low volume OPCAB centres. These results might be true only for 
cardiac surgeons and anaesthesiologists who are fully accustomed to OPCAB.  
Conclusions 
OPCAB is a valuable technique that may reduce morbidities in the setting of high risk patients. 
Despite completeness of revascularization can be achieved in the majority of OPCAB cases, 
OPCAB remains associated with a significantly higher rate of incomplete revascularization 
that can ultimately translate into a marginal but significant reduction in late survival rates.  
when compared to ONCAB. In the light of these results, a 2-step hybrid approach might 
represent a valid option to reach the completeness of the myocardial revascularization. 
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Table 1. Characteristics of the unmatched population.  
   ONCAB OPCAB p SMD 
n  7128 7424   
Age (mean (sd))  65.65 (9.31) 66.16 (9.56) 0.001 0.054 
Female n(%) 1285 (18.0) 1364 (18.4) 0.604 0.009 
BMI (mean (sd))  27.62 (4.45) 28.12 (4.42) <0.001 0.113 
CCS III-IV n(%) 3722 (52.2) 3355 (45.2) <0.001 0.141 
NYHA III-IV n(%) 2188 (30.7) 2070 (27.9) <0.001 0.062 
MI within 30 days n(%) 1265 (17.7) 1509 (20.3) <0.001 0.066 
PCI n(%) 305 ( 4.3) 535 ( 7.2) <0.001 0.126 
DM orally treated n(%) 727 (10.2) 788 (10.6) 0.428 0.014 
DM on insulin n(%) 503 ( 7.1) 543 ( 7.3) 0.569 0.010 
Smoking n(%) 951 (13.3) 958 (12.9) 0.449 0.013 
Cr>200 mmol/l n(%) 178 ( 2.5) 186 ( 2.5) 1.000 0.001 
COPD n(%) 542 ( 7.6) 559 ( 7.5) 0.890 0.003 
CVA n(%) 272 ( 3.8) 261 ( 3.5) 0.358 0.016 
PVD n(%) 718 (10.1) 715 ( 9.6) 0.386 0.015 
AF n(%) 253 ( 3.5) 242 ( 3.3) 0.359 0.016 
NVD n (%)    <0.001 0.351 
    LAD only   278 ( 3.9) 768 (10.3)   
    LAD plus CX or RCA  1493 (20.9) 2184 (29.4)   
    LAD, CX and RCA 5357 (75.2) 4472 (60.2)   
LMD n(%) 1703 (23.9) 1924 (25.9) 0.005 0.047 
LVEF 30-49% n(%) 1591 (22.3) 1500 (20.2) 0.002 0.052 
LVEF <30% n(%) 425 ( 6.0) 307 ( 4.1) <0.001 0.084 
Preop IABP n(%) 111 ( 1.6) 101 ( 1.4) 0.357 0.016 
Non-elective n(%) 3460 (48.5) 3374 (45.4) <0.001 0.062 
Preop Shock n(%) 69 ( 1.0) 24 ( 0.3) <0.001 0.081 
RA n(%) 825 (11.6) 1562 (21.0) <0.001 0.258 
SV n(%) 6428 (90.2) 5835 (78.6) <0.001 0.323 
RITA n(%) 634 ( 8.9) 473 ( 6.4) <0.001 0.095 
LITA n(%) 6552 (91.9) 7054 (95.0) <0.001 0.126 
Year of surgey (mean (sd))  2003.59 (5.81) 2006.23 (4.19) <0.001 0.520 
OPCAB: off-pump coronary artery bypass; ONCAB: on-pump coronary artery bypass; SMD: 
standardized mean difference; BMI: body mass index; CCS: Canadian Cardiovascular Society; 
NYHA: New York Heart Association grade; MI: myocardial infarction; PCI: percutaneous 
coronary intervention; DM: diabetes mellitus; Cr: creatinine; COPD: chronic obstructive 
pulmonary disease; CVA: cerebrovascular accident; PVD: peripheral vascular disease; AF: 
atrial fibrillation; NVD: number of vessels diseased; LMD: left main disease; LVEF: left 
ventricular ejection fraction; IABP: intra-aortic balloon pump; RA: Radial Artery; SV: 
saphenous vein graft RITA: right internal thoracic artery; LITA: left internal thoracic artery.  
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Table 2. Intraoperative data in the propensity matched group 
 ONCAB OPCAB p SMD 
n  5423 5423   
Age (mean (sd))  66.27 (9.44) 66.14 (9.54) 0.476 0.014 
Female n(%) 970 (17.9) 987 (18.2) 0.690 0.008 
BMI (mean (sd))  27.97 (4.51) 28.02 (4.36) 0.510 0.013 
CCS III-IV n(%) 2618 (48.3) 2521 (46.5) 0.065 0.036 
NYHA III-IV n(%) 1593 (29.4) 1583 (29.2) 0.849 0.004 
MI within 30 days n(%) 1108 (20.4) 1067 (19.7) 0.337 0.019 
PCI n(%) 292 ( 5.4) 338 ( 6.2) 0.065 0.036 
DM orally treated n(%) 566 (10.4) 586 (10.8) 0.554 0.012 
DM on insulin n(%) 415 ( 7.7) 402 ( 7.4) 0.662 0.009 
Smoking n(%) 725 (13.4) 735 (13.6) 0.800 0.005 
Cr>200 mmol/l n(%) 132 ( 2.4) 149 ( 2.7) 0.333 0.020 
COPD n(%) 423 ( 7.8) 422 ( 7.8) 1.000 0.001 
CVA n(%) 207 ( 3.8) 206 ( 3.8) 1.000 0.001 
PVD n(%) 559 (10.3) 550 (10.1) 0.800 0.005 
AF n(%) 179 ( 3.3) 187 ( 3.4) 0.710 0.008 
NVD n (%)    <0.001 0.092 
    LAD only   274 ( 5.1) 370 ( 6.8)   
    LAD plus CX or RCA  1344 (24.8) 1443 (26.6)   
    LAD, CX and RCA 3805 (70.2) 3610 (66.6)   
LMD n(%) 1448 (26.7) 1426 (26.3) 0.648 0.009 
LVEF 30-49% n(%) 1194 (22.0) 1157 (21.3) 0.402 0.017 
LVEF <30% n(%) 261 ( 4.8) 256 ( 4.7) 0.857 0.004 
Preop IABP n(%) 79 ( 1.5) 79 ( 1.5) 1.000 <0.001 
Non-elective n(%) 2621 (48.3) 2555 (47.1) 0.211 0.024 
Preop Shock n(%) 24 ( 0.4) 24 ( 0.4) 1.000 <0.001 
RA n(%) 815 (15.0) 928 (17.1) 0.003 0.057 
SV n(%) 4741 (87.4) 4614 (85.1) <0.001 0.068 
RITA n(%) 405 ( 7.5) 375 ( 6.9) 0.281 0.021 
LITA n(%) 5093 (93.9) 5105 (94.1) 0.656 0.009 
Year of surgey (mean 
(sd))  
2005.31 (5.53) 2005.69 (4.20) <0.001 0.077 
OPCAB: off-pump coronary artery bypass; ONCAB: on-pump coronary artery bypass; SMD: 
standardized mean difference; BMI: body mass index; CCS: Canadian Cardiovascular Society; 
NYHA: New York Heart Association grade; MI: myocardial infarction; PCI: percutaneous 
coronary intervention; DM: diabetes mellitus; Cr: creatinine; COPD: chronic obstructive 
pulmonary disease; CVA: cerebrovascular accident; PVD: peripheral vascular disease; AF: 
atrial fibrillation; NVD: number of vessels diseased; LMD: left main disease; LVEF: left 
ventricular ejection fraction; IABP: intra-aortic balloon pump; RA: Radial Artery; SV: 
saphenous vein graft RITA: right internal thoracic artery; LITA: left internal thoracic artery.  
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Table 3. Intraoperative data and postoperative outcomes in the propensity matched 
group 
 ONCAB OPCAB p 
n  5423 5423  
Intraoperative data 
IR n(%) 373 ( 6.9) 740 (13.6) <0.001 
N of grafts n(%)    <0.001 
     1  230 ( 4.2) 407 ( 7.5)  
     2  1337 (24.7) 1813 (33.4)  
     3  2899 (53.5) 2709 (50.0)  
     4  912 (16.8) 478 ( 8.8)  
     5  44 ( 0.8) 15 ( 0.3)  
     6  1 ( 0.0) 1 ( 0.0)  
Territory grafted    
  LAD n(%) 5234 (96.5) 5253 (96.9) 0.334 
  RCA n(%) 3791 (69.9) 3484 (64.2) <0.001 
  CX n(%) 4402 (81.2) 3868 (71.3) <0.001 
  DIA n(%) 1185 (21.9) 1017 (18.8) <0.001 
    
Postoperative complications 
Re-exploration for bleeding,  n(%) 176 ( 3.2) 128 ( 2.4) 0.006 
Sternal wound  reconstruction, n(%) 36 ( 0.7) 33 ( 0.6) 0.809 
Cerebrovascular accident, n(%) 85 ( 1.6) 54 ( 1.0) 0.04 
Dialysis n(%) 134 ( 2.5) 108 ( 2.0) 0.104 
Postoperative IABP, n(%) 173 ( 3.2) 103 ( 1.9) <0.001 
Mortality at 30 days n(%) 77 ( 1.4) 74 ( 1.4) 0.870 
OPCAB: off-pump coronary artery bypass; ONCAB: on-pump coronary artery bypass; IR: 
incomplete revascularization; LAD: left anterior descending artery; CX: circumflex artery; 
RCA: right coronary artery; DIA: diagonal branch; IABP: intra-aortic balloon pump 
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Table 4. Survival analysis in the propensity matched groups 
 
ONCAB      
Interval 
(years) 
No. at risk No. of 
events 
No. lost to 
follow-up 
Survival 
probability 
95%CI 
      
0.0-- 0.0 5423 0 0 99.9 99.9--100.0 
0.0-- 3.0 5423 328 943 93.4 92.7-- 94.1 
3.0-- 6.0 4152 267 634 86.8 85.8-- 87.8 
6.0-- 9.0 3251 294 537 78.3 77.1-- 79.6 
9.0--12.0 2420 275 766 67.4 65.8-- 69.1 
      
OPCAB      
Interval 
(years) 
No. at risk No. of 
events 
No. lost to 
follow-up 
Survival 
probability 
95%CI  
0.0-- 0.0 5423 0 0 99.9 99.9--100.0 
0.0-- 3.0 5423 363 417 93.1 92.4-- 93.8 
3.0-- 6.0 4643 331 885 85.8 84.8-- 86.8 
6.0-- 9.0 3427 337 1015 75.7 74.4-- 77.1 
9.0--12.0 2075 238 837 64.4 62.7-- 66.2 
OPCAB: off-pump coronary artery bypass; ONCAB: on-pump coronary artery bypass 
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Table 5. Risk factors for late death in a fully adjusted analysis (original sample) 
        Variable  Hazard Ratio 95%CI    p-value  
OPCAB  1.06 [0.99;1.14] 0.10 
Age  1.07 [1.07;1.08] < 0.001 
Female  0.94 [0.86;1.02] 0.13 
BMI 1.00 [0.99;1.01] 0.51 
NYHA III-IV 1.24 [1.15;1.33] < 0.001 
CCS III-IV 1.04 [0.96; 1.12] 0.34 
MI within 30 days  0.92 [0.82;1.02] 0.10 
PCI  0.98 [0.79;1.20] 0.82 
DM orally treated  1.54 [1.39;1.69] < 0.001 
DM on insulin 1.80 [1.61;2.01] < 0.001 
Smoking  1.62 [1.47;1.79] < 0.001 
Cr>200  2.03 [1.71;2.41] < 0.001 
COPD  1.64 [1.47;1.82] < 0.001 
CVA  1.55 [1.35;1.78] < 0.001 
PVD  1.50 [1.36;1.64] < 0.001 
AF  1.45 [1.26;1.66] < 0.001 
NVD 1.06 [1.00;1.13] 0.048 
LMD  1.11 [1.03;1.20] 0.009 
LVEF 30-49% 1.44 [1.34;1.55] < 0.001 
LVEF <30% 2.36 [2.10;2.66] < 0.001 
Preop IABP  1.07 [0.78;1.47] 0.65 
Non-elective  1.07 [0.99;1.14] 0.07 
Preop shock  1.29 [0.92;1.81] 0.14 
Year of surgery  0.98 [0.97;0.99] 0.003 
RA  0.91 [0.82;1.01] 0.08 
RITA  0.70 [0.59;0.84] < 0.001 
LITA  0.74 [0.66;0.82] < 0.001 
Incomplete revascularization  1.26 [1.14;1.39] < 0.001 
OPCAB: off-pump coronary artery bypass; ONCAB: on-pump coronary artery bypass; SMD: 
standardized mean difference; BMI: body mass index; CCS: Canadian Cardiovascular Society; 
NYHA: New York Heart Association grade; MI: myocardial infarction; PCI: percutaneous 
coronary intervention; DM: diabetes mellitus; Cr: creatinine; COPD: chronic obstructive 
pulmonary disease; CVA: cerebrovascular accident; PVD: peripheral vascular disease; AF: 
atrial fibrillation; NVD: number of vessels diseased; LMD: left main disease; LVEF: left 
ventricular ejection fraction; IABP: intra-aortic balloon pump; RA: Radial Artery; RITA: right 
internal thoracic artery; LITA: left internal thoracic artery.  
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Figure Legends 
Figure 1. Frequency of off-pump coronary artery bypass (OPCAB, red) and on-pump coronary artery bypass (ONCAB) during the study period.  
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Figure 2: Changes in standardized mean difference (SMD) after matching for all variables 
included in the PS model.  
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Figure 3. Survival in off-pump coronary artery bypass (OPCAB, red) and on-pump coronary artery bypass (ONCAB) in the matched sample (left) 
and according to the completeness of revascularization (CR: complete revascularization; IR: incomplete revascularization, right)  
 
